Ignite Creation Date:
2024-05-06 @ 8:07 PM
Last Modification Date:
2024-10-26 @ 3:20 PM
Study NCT ID:
NCT06251180
Status:
RECRUITING
Last Update Posted:
2024-04-16
First Post:
2024-02-01
Brief Title:
Phase Ib Study of Rocbrutinib in Combination With R-CHOP in Patients With Newly Diagnosed B-cell Non-Hodgkin Lymphoma
Sponsor:
Guangzhou Lupeng Pharmaceutical Company LTD
Organization:
Guangzhou Lupeng Pharmaceutical Company LTD
Organization Data
Organization:
Guangzhou Lupeng Pharmaceutical Company LTD
Class:
INDUSTRY
Study ID:
LP-168-CN301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Guangzhou Lupeng Pharmaceutical Company LTD
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None